Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance-Reference-Cited by-同舟云学术

Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance

Published:2019-02 Issue:1 Volume:6 Page:e000890
ISSN:2053-3624
Container-title:Open Heart
language:en
Short-container-title:Open Heart

Author:

DiNicolantonio James J^ORCID,McCarty Mark,OKeefe James^ORCID

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference147 articles.

1. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk;Tang;N Engl J Med Overseas Ed,2013

2. Senthong V , Wang Z , Li XS , et al . Intestinal Microbiota‐Generated Metabolite Trimethylamine‐ N‐ Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort. J Am Heart Assoc 2016;5.doi:10.1161/JAHA.115.002816

3. Lever M , George PM , Slow S , et al . Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study. PLoS One 2014;9:e114969.doi:10.1371/journal.pone.0114969

4. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction

5. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors;Li;Eur Heart J,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases;The Journal of Nutritional Biochemistry;2024-10

2. The interaction between dietary nitrates/nitrites intake and gut microbial metabolites on metabolic syndrome: a cross-sectional study;Frontiers in Public Health;2024-09-11

3. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics;Nutrients;2024-09-11

4. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-07-23

5. Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity;Frontiers in Endocrinology;2023-10-02